Intercure Ltd. current report, Q2 FY2024

InterCure Ltd. Form 6-K Summary

Business Context and Reporting Period

InterCure Ltd., an Israeli foreign private issuer, filed a Form 6-K covering May 2024. The filing was submitted on May 21, 2024, and references a press release dated the same day as Exhibit 99.1.

Financial Metrics

The filing text provided does not include revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide financial or operational comparisons with a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not include guidance, outlook, management commentary, risk factors, contingencies, or unusual items. The referenced May 21, 2024 press release is not included in the provided text.

Key Facts to Verify

  • Obtain and review Exhibit 99.1, the May 21, 2024 press release.
  • Verify whether the press release contains financial results, operating metrics, guidance, or material corporate developments.
  • Confirm any disclosures regarding liquidity, financing, debt, regulatory matters, or other contingencies.